Published in Br J Clin Pharmacol on January 01, 1985
Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol (1985) 1.22
Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol (1985) 1.09
The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol (1985) 1.05
The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man. Br J Clin Pharmacol (1993) 1.03
Gastric, intestinal and colonic absorption of metoprolol in the rat. Br J Clin Pharmacol (1985) 0.96
Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption. Br J Clin Pharmacol (1985) 0.95
Investigation of drug absorption from the gastrointestinal tract of man. V. Effect of the beta-adrenoceptor antagonist, metoprolol, on postprandial gastric function. Br J Clin Pharmacol (1985) 0.90
The fraction dose absorbed, in humans, and high jejunal human permeability relationship. Mol Pharm (2012) 0.86
Effect of pH on sublingual absorption of oxycodone hydrochloride. AAPS PharmSciTech (2006) 0.86
Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Mol Pharm (2013) 0.86
Ethyl cellulose and hydroxypropyl methyl cellulose buoyant microspheres of metoprolol succinate: Influence of pH modifiers. Int J Pharm Investig (2013) 0.83
Influence of splitting on dissolution properties of metoprolol tablets. Bosn J Basic Med Sci (2009) 0.78
Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine. AAPS J (2013) 0.78
Does coronary artery bypass surgery affect metoprolol bioavailability. Eur J Clin Pharmacol (2007) 0.77
The volume and energy content of meals as determinants of gastric emptying. J Physiol (1975) 3.14
Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology (1976) 2.56
A comparison of stable and 14 C-labelled polyethylene glycol as volume indicators in the human jejunum. Gut (1972) 1.98
Control of gastric emptying by osmolality of duodenal contents in man. Gastroenterology (1975) 1.92
Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique. Gastroenterology (1970) 1.86
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci (1979) 1.72
Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man. Gastroenterology (1977) 1.35
Simultaneous measurement of antroduodenal motility, gastric emptying, and duodenogastric reflux in man. Gut (1979) 1.19
The gastric response to a transpyloric duodenal tube. Gut (1975) 1.04
Investigation of drug absorption from the gastrointestinal tract of man. V. Effect of the beta-adrenoceptor antagonist, metoprolol, on postprandial gastric function. Br J Clin Pharmacol (1985) 0.90
Gas chromatographic determination of metoprolol in human plasma. J Chromatogr (1983) 0.86
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54
Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology (1995) 2.47
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol (2008) 2.28
Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol (1998) 2.03
Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest (1985) 2.00
Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J (1996) 1.93
Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol (1996) 1.89
Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73
Clinical characteristics of Crohn's disease in 72 families. Gastroenterology (1996) 1.70
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther (2011) 1.69
Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum (1991) 1.65
Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut (2005) 1.65
Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci (1989) 1.63
Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut (1986) 1.63
Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology (1983) 1.62
Effect of prostaglandin E 1 on glucose, water, and electrolyte absorption in the human jejunum. Gastroenterology (1973) 1.62
Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61
Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut (1985) 1.60
Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut (1994) 1.57
Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease"). Digestion (1968) 1.56
Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut (1993) 1.54
High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. J Chromatogr (1985) 1.48
Evidence of gastritis with several Helicobacter pylori strains. Lancet (1989) 1.43
Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin. Lancet (1978) 1.41
[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression. Aliment Pharmacol Ther (2008) 1.40
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1992) 1.39
[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]. Rev Epidemiol Sante Publique (1999) 1.39
Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology (1981) 1.39
Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis. Circulation (1976) 1.37
The method of intraluminal perfusion of the human small intestine. I. Principle and technique. Digestion (1973) 1.37
Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci (1997) 1.33
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol (1988) 1.29
Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation. Gastroenterology (1987) 1.27
Antibiotics in Crohn's disease. Gut (2001) 1.25
Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr (1988) 1.25
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol (2001) 1.24
Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol (1985) 1.22
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut (2004) 1.20
Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol (1981) 1.19
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18
Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos (1997) 1.17
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology (1999) 1.17
[Study of the progression of an ordinary meal in the human small bowel by a scintigraphic method (author's transl)]. Gastroenterol Clin Biol (1979) 1.14
Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant (2001) 1.14
Impaired bacterial flora in human excluded colon. Gut (1989) 1.12
Cap polyposis occurring in the postoperative course of pelvic surgery. Gut (1994) 1.12
Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease. Clin Chem (1988) 1.11
Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut (1995) 1.09
Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol (1985) 1.09
Villous adenomas of the rectum. Results of endoscopic treatment with argon and Nd:YAG lasers. Gastroenterology (1985) 1.09
The Quebec Association of Gastroenterology position paper on colorectal cancer screening - 2003. Can J Gastroenterol (2004) 1.08
[Clinical, anatomo-pathological and immunochemical study of a further case of alpha chain disease followed for 5 years]. Rev Eur Etud Clin Biol (1972) 1.08
Amyloidosis associated with primary agammaglobulinemia, severe diarrhea and familial hypogammaglobulinemia. Am J Med (1969) 1.06
Inflammatory bowel disease in spouses and their offspring. Gastroenterology (2001) 1.05
Sulfinpyrazone kinetics after intravenous and oral administration. Clin Pharmacol Ther (1979) 1.05
The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol (1985) 1.05
Anticipation in familial Crohn's disease. Gut (1998) 1.04
Bacterial translocation in colorectal cancers. Gastroenterol Clin Biol (1990) 1.04
Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. Br J Clin Pharmacol (1998) 1.04
Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital. J Clin Microbiol (1996) 1.03
Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. Am J Med Genet (1994) 1.02
Colocalization of a high molecular mass phosphoprotein of the nuclear matrix (p255) with spliceosomes. J Cell Sci (1995) 1.02
Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone Marrow Transplant (2005) 1.01
[A further case of alpha chain disease in a Eurasian]. Ann Med Interne (Paris) (1970) 1.01
Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol (1992) 1.01
Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea. Gastroenterology (1975) 1.00
Determination of metoprolol and its alpha-hydroxylated metabolite in human plasma by high-performance liquid chromatography. J Chromatogr (1984) 1.00
[Measurement of gastric transepithelial potential difference. Effect of provocative agents (aspirin, alcohol) and gastric dressings]. Gastroenterol Clin Biol (1985) 1.00
Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet (1987) 1.00
Evidence of lymphocyte alveolitis in Crohn's disease. Chest (1985) 1.00
Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms. Chest (1986) 0.99
Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody. J Immunol (1995) 0.99
Diarrhoea associated with medullary carcinoma of the thyroid. Gut (1969) 0.98
Effect of pectin on jejunal glucose absorption and unstirred layer thickness in normal man. Gut (1984) 0.98
Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant (2004) 0.97